 | • レポートコード：QYR9ST03700 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、オリゴヌクレオチド治療薬の世界市場について調査・分析し、オリゴヌクレオチド治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アンチセンス/ RNAiオリゴヌクレオチド、その他）、用途別（神経障害、癌、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のオリゴヌクレオチド治療薬市場動向 ・主要企業別マーケットシェア ・オリゴヌクレオチド治療薬の種類別市場規模2014-2019 （アンチセンス/ RNAiオリゴヌクレオチド、その他） ・オリゴヌクレオチド治療薬の用途別市場規模2014-2019 （神経障害、癌、その他） ・オリゴヌクレオチド治療薬の北米市場：主要企業・種類別/用途別市場規模 ・オリゴヌクレオチド治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・オリゴヌクレオチド治療薬の中国市場：主要企業・種類別/用途別市場規模 ・オリゴヌクレオチド治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・オリゴヌクレオチド治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・オリゴヌクレオチド治療薬のインド市場：主要企業・種類別/用途別市場規模 ・オリゴヌクレオチド治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Arrowhead Pharmaceuticals、GlaxoSmithKline、Ionis Pharmaceuticals、miRagen Therapeutics、Sarepta Therapeutics） ・オリゴヌクレオチド治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Oligonucleotides are short nucleotides sequences of DNA or RNA molecules called oligomers. Oligonucleotide therapeutics target and inhibit the expression of certain diseases-causing genes, thus forming a new class of therapeutics to treat chronic diseases.In terms of geographic regions, the North Americas accounted for the major share in the antisense oligonucleotides market in 2017. The major reason for the market growth in this region is due to the increasing approval of products.
In 2018, the global Oligonucleotide Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Oligonucleotide Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oligonucleotide Therapeutics development in United States, Europe and China.
The key players covered in this study
Arrowhead Pharmaceuticals
GlaxoSmithKline
Ionis Pharmaceuticals
miRagen Therapeutics
Sarepta Therapeutics
…
Market segment by Type, the product can be split into
Antisense/RNAi oligonucleotides
Others
Market segment by Application, split into
Neurological disorders
Cancer
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oligonucleotide Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Oligonucleotide Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oligonucleotide Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oligonucleotide Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Antisense/RNAi oligonucleotides
1.4.3 Others
1.5 Market by Application
1.5.1 Global Oligonucleotide Therapeutics Market Share by Application (2014-2025)
1.5.2 Neurological disorders
1.5.3 Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Oligonucleotide Therapeutics Market Size
2.2 Oligonucleotide Therapeutics Growth Trends by Regions
2.2.1 Oligonucleotide Therapeutics Market Size by Regions (2014-2025)
2.2.2 Oligonucleotide Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Oligonucleotide Therapeutics Market Size by Manufacturers
3.1.1 Global Oligonucleotide Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Oligonucleotide Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Oligonucleotide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Oligonucleotide Therapeutics Key Players Head office and Area Served
3.3 Key Players Oligonucleotide Therapeutics Product/Solution/Service
3.4 Date of Enter into Oligonucleotide Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Oligonucleotide Therapeutics Market Size by Type (2014-2019)
4.2 Global Oligonucleotide Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Oligonucleotide Therapeutics Market Size (2014-2019)
5.2 Oligonucleotide Therapeutics Key Players in United States
5.3 United States Oligonucleotide Therapeutics Market Size by Type
5.4 United States Oligonucleotide Therapeutics Market Size by Application
6 Europe
6.1 Europe Oligonucleotide Therapeutics Market Size (2014-2019)
6.2 Oligonucleotide Therapeutics Key Players in Europe
6.3 Europe Oligonucleotide Therapeutics Market Size by Type
6.4 Europe Oligonucleotide Therapeutics Market Size by Application
7 China
7.1 China Oligonucleotide Therapeutics Market Size (2014-2019)
7.2 Oligonucleotide Therapeutics Key Players in China
7.3 China Oligonucleotide Therapeutics Market Size by Type
7.4 China Oligonucleotide Therapeutics Market Size by Application
8 Japan
8.1 Japan Oligonucleotide Therapeutics Market Size (2014-2019)
8.2 Oligonucleotide Therapeutics Key Players in Japan
8.3 Japan Oligonucleotide Therapeutics Market Size by Type
8.4 Japan Oligonucleotide Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Oligonucleotide Therapeutics Market Size (2014-2019)
9.2 Oligonucleotide Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Oligonucleotide Therapeutics Market Size by Type
9.4 Southeast Asia Oligonucleotide Therapeutics Market Size by Application
10 India
10.1 India Oligonucleotide Therapeutics Market Size (2014-2019)
10.2 Oligonucleotide Therapeutics Key Players in India
10.3 India Oligonucleotide Therapeutics Market Size by Type
10.4 India Oligonucleotide Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Oligonucleotide Therapeutics Market Size (2014-2019)
11.2 Oligonucleotide Therapeutics Key Players in Central & South America
11.3 Central & South America Oligonucleotide Therapeutics Market Size by Type
11.4 Central & South America Oligonucleotide Therapeutics Market Size by Application
12 International Players Profiles
12.1 Arrowhead Pharmaceuticals
12.1.1 Arrowhead Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oligonucleotide Therapeutics Introduction
12.1.4 Arrowhead Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2014-2019)
12.1.5 Arrowhead Pharmaceuticals Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oligonucleotide Therapeutics Introduction
12.2.4 GlaxoSmithKline Revenue in Oligonucleotide Therapeutics Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Ionis Pharmaceuticals
12.3.1 Ionis Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oligonucleotide Therapeutics Introduction
12.3.4 Ionis Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2014-2019)
12.3.5 Ionis Pharmaceuticals Recent Development
12.4 miRagen Therapeutics
12.4.1 miRagen Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oligonucleotide Therapeutics Introduction
12.4.4 miRagen Therapeutics Revenue in Oligonucleotide Therapeutics Business (2014-2019)
12.4.5 miRagen Therapeutics Recent Development
12.5 Sarepta Therapeutics
12.5.1 Sarepta Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oligonucleotide Therapeutics Introduction
12.5.4 Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Business (2014-2019)
12.5.5 Sarepta Therapeutics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Oligonucleotide Therapeutics Key Market Segments
Table Key Players Oligonucleotide Therapeutics Covered
Table Global Oligonucleotide Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Oligonucleotide Therapeutics Market Size Market Share by Type 2014-2025
Figure Antisense/RNAi oligonucleotides Figures
Table Key Players of Antisense/RNAi oligonucleotides
Figure Others Figures
Table Key Players of Others
Table Global Oligonucleotide Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Neurological disorders Case Studies
Figure Cancer Case Studies
Figure Others Case Studies
Figure Oligonucleotide Therapeutics Report Years Considered
Table Global Oligonucleotide Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Oligonucleotide Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Oligonucleotide Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Oligonucleotide Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Oligonucleotide Therapeutics Market Share by Regions 2014-2019
Figure Global Oligonucleotide Therapeutics Market Share by Regions 2014-2019
Figure Global Oligonucleotide Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Oligonucleotide Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Oligonucleotide Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Oligonucleotide Therapeutics Market Share by Manufacturers in 2018
Table Global Oligonucleotide Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oligonucleotide Therapeutics Product/Solution/Service
Table Date of Enter into Oligonucleotide Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oligonucleotide Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Oligonucleotide Therapeutics Market Size Share by Type (2014-2019)
Figure Global Oligonucleotide Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Oligonucleotide Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Oligonucleotide Therapeutics Market Size Share by Application (2014-2019)
Figure Global Oligonucleotide Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Oligonucleotide Therapeutics Revenue Market Share by Application in 2018
Figure United States Oligonucleotide Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Oligonucleotide Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Oligonucleotide Therapeutics Market Share (2018-2019)
Table United States Oligonucleotide Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Oligonucleotide Therapeutics Market Share by Type (2014-2019)
Table United States Oligonucleotide Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Oligonucleotide Therapeutics Market Share by Application (2014-2019)
Figure Europe Oligonucleotide Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Oligonucleotide Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Oligonucleotide Therapeutics Market Share (2018-2019)
Table Europe Oligonucleotide Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Oligonucleotide Therapeutics Market Share by Type (2014-2019)
Table Europe Oligonucleotide Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Oligonucleotide Therapeutics Market Share by Application (2014-2019)
Figure China Oligonucleotide Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Oligonucleotide Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Oligonucleotide Therapeutics Market Share (2018-2019)
Table China Oligonucleotide Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Oligonucleotide Therapeutics Market Share by Type (2014-2019)
Table China Oligonucleotide Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Oligonucleotide Therapeutics Market Share by Application (2014-2019)
Figure Japan Oligonucleotide Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Oligonucleotide Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Oligonucleotide Therapeutics Market Share (2018-2019)
Table Japan Oligonucleotide Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Oligonucleotide Therapeutics Market Share by Type (2014-2019)
Table Japan Oligonucleotide Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Oligonucleotide Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Oligonucleotide Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Oligonucleotide Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Oligonucleotide Therapeutics Market Share (2018-2019)
Table Southeast Asia Oligonucleotide Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Oligonucleotide Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Oligonucleotide Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Oligonucleotide Therapeutics Market Share by Application (2014-2019)
Figure India Oligonucleotide Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Oligonucleotide Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Oligonucleotide Therapeutics Market Share (2018-2019)
Table India Oligonucleotide Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Oligonucleotide Therapeutics Market Share by Type (2014-2019)
Table India Oligonucleotide Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Oligonucleotide Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Oligonucleotide Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Oligonucleotide Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Oligonucleotide Therapeutics Market Share (2018-2019)
Table Central & South America Oligonucleotide Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Oligonucleotide Therapeutics Market Share by Type (2014-2019)
Table Central & South America Oligonucleotide Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Oligonucleotide Therapeutics Market Share by Application (2014-2019)
Table Arrowhead Pharmaceuticals Company Details
Table Arrowhead Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2014-2019) (Million US$)
Figure Arrowhead Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Business (2014-2019)
Table Arrowhead Pharmaceuticals Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Oligonucleotide Therapeutics Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Oligonucleotide Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Ionis Pharmaceuticals Company Details
Table Ionis Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2014-2019)(Million US$)
Figure Ionis Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Business (2014-2019)
Table Ionis Pharmaceuticals Recent Development
Table miRagen Therapeutics Company Details
Table miRagen Therapeutics Revenue in Oligonucleotide Therapeutics Business (2014-2019)(Million US$)
Figure miRagen Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2014-2019)
Table miRagen Therapeutics Recent Development
Table Sarepta Therapeutics Company Details
Table Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Business (2014-2019)(Million US$)
Figure Sarepta Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2014-2019)
Table Sarepta Therapeutics Recent Development
Table Global Oligonucleotide Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Oligonucleotide Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Oligonucleotide Therapeutics Market Size Share by Regions in 2025
Figure United States Oligonucleotide Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Oligonucleotide Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Oligonucleotide Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Oligonucleotide Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Oligonucleotide Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Oligonucleotide Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Oligonucleotide Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Oligonucleotide Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Oligonucleotide Therapeutics Market Size by Product (2019-2025)
Figure Global Oligonucleotide Therapeutics Market Size by Product in 2025
Table Global Oligonucleotide Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Oligonucleotide Therapeutics Market Size by Application (2019-2025)
Figure Global Oligonucleotide Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
アンチセンス及びRNAi治療薬の世界市場：市場規模・現状・予測 Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (…- オリゴヌクレオチド合成の世界市場：市場規模・現状・予測 Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the de…
- 中枢神経系疾患治療法の世界市場：市場規模・現状・予測 Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Depression is the dominated market of CNS Disorders Therapeutics In 2018, the global Central Nervous System Disorders Therapeutics mark…
- 代謝障害治療薬の世界市場：市場規模・現状・予測 Metabolic Disorders Therapeutics is a drug used to treat the symptoms of metabolic disorders caused by a variety of causes.Due to the increasing pressure of modern life and the spread of unhealthy lifestyles, the global metabolic disorder treatment market will continue to grow strongly during the fo…
- 筋骨格障害治療薬の世界市場：市場規模・現状・予測 Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide …